Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GCSF for Bone Marrow Sparing Radiotherapy Planning
NCT04514692Phase 2Terminated
- Sponsor
- Stanford University
- Start
- Feb 2021
- Primary completion
- Sep 2023
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of filgrastim in neutropenia, sponsored by Stanford University. Started Feb 2021; status: terminated.
02
Drugs
filgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT04514692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04514692.